[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]

[[ timeLabel ]] WATCH LIVE:

Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial

Faster, Cleaner, Better.

Insys Therapeutics Inc (INSYQ)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2017	09-2017	06-2017	03-2017	12-2016
Assets
Current Assets
Cash & Cash Equivalents	31,999	35,755	49,830	68,373	104,642
Marketable Securities	85,189	85,891	91,786	86,914	78,238
Receivables	21,513	23,249	23,972	13,313	20,654
Inventories	17,408	18,424	19,988	21,288	20,414
TOTAL	$175,942	$179,863	$197,186	$196,936	$229,643

Non-Current Assets
PPE Net	55,174	53,931	49,139	46,009	43,172
Investments And Advances	46,733	55,514	61,342	63,193	53,796
Other Non-Current Assets	1,231	33,778	29,961	31,458	29,525
TOTAL	$103,138	$143,223	$140,442	$140,660	$126,493

Total Assets	$279,080	$323,086	$337,628	$337,596	$356,136

Liabilities
Current Liabilities
Accounts payable and accrued liabilities	30,438	31,226	23,016	28,205	27,359
Accrued Expenses	175,632	176,731	40,045	33,655	51,255
TOTAL	$207,179	$208,897	$63,061	$61,860	$78,614

Non-Current Liabilities
Deferred Revenues	1,109	940	N/A	N/A	N/A
Other Non-Current Liabilities	5,692	8,172	8,188	7,950	7,933
TOTAL	$5,692	$8,172	$8,188	$7,950	$7,933

Total Liabilities	$212,871	$217,069	$71,249	$69,810	$86,547

Shareholders' Equity
Shares Outstanding, K	73,764	73,317	72,697	72,125	71,957
Common Shares	736	731	727	721	719
Retained earnings	-212,424	-168,364	-2,044	6,140	12,664
Other shareholders' equity	-459	-259	-272	-248	-323
TOTAL	$66,209	$106,017	$266,379	$267,786	$269,589

Total Liabilities And Equity	$279,080	$323,086	$337,628	$337,596	$356,136